BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38192989)

  • 1.
    Liang C; Chen Y; Chen S; She J; Shi Q; Wang P
    Transl Cancer Res; 2023 Dec; 12(12):3641-3652. PubMed ID: 38192989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
    Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
    PeerJ; 2023; 11():e15654. PubMed ID: 37520246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer.
    Huang G; Xiao S; Jiang Z; Zhou X; Chen L; Long L; Zhang S; Xu K; Chen J; Jiang B
    Front Endocrinol (Lausanne); 2023; 14():1185799. PubMed ID: 37351109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
    Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
    J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
    Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
    Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.
    Li L; Hu Y; Li X; Ju B
    Medicine (Baltimore); 2024 Apr; 103(15):e37688. PubMed ID: 38608099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of
    Liu X; Cui Q; Qin N
    Transl Cancer Res; 2024 Mar; 13(3):1225-1240. PubMed ID: 38617516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-related gene
    Nong B; Su T; Jin M; Huang J; Huang A; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2962-2976. PubMed ID: 35116604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer.
    Tang S; Zhang Y; Lin X; Wang H; Yong L; Zhang H; Cai F
    Oncol Lett; 2022 Aug; 24(2):285. PubMed ID: 35814828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 15. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 17. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer.
    Gu J; Wang Z; Wang BO; Ma X
    Front Oncol; 2023; 13():1097015. PubMed ID: 36937436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 20. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.